Antihypertensive Drugs Market
Antihypertensive Drugs Market - Global Industry Assessment & Forecast
Segments Covered
- By Drug Class Diuretics, ACE Inhibitors, Calcium Channel Blockers, Beta-adrenergic Blockers, Vasodilators, Others
- By Type Primary Hypertension, Secondary Hypertension
- By End User Retail Pharmacy, Hospital Pharmacy, E-commerce
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2023 |
Forecast Years: | 2024 - 2032 |
Historical Years: | 2018 - 2022 |
Revenue 2023: | USD 25.5 Billion |
Revenue 2032: | USD 33.86 Billion |
Revenue CAGR (2024 - 2032): | 3.2% |
Fastest Growing Region (2024 - 2032) | Asia Pacific |
Largest Region (2023): | North America 4 |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
Antihypertensive Drugs Market Segment Analysis
- Antihypertensive Drugs Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- Antihypertensive Drugs Type Outlook (Revenue, USD Million, 2018 - 2030)
- Primary Hypertension
- Secondary Hypertension
- Antihypertensive Drugs End User Outlook (Revenue, USD Million, 2018 - 2030)
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
-
North America Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
-
North America Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- U.S.
- U.S. Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- U.S. Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
- U.S. Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- U.S. Antihypertensive Drugs Market, by Drug Class
- Canada
- Canada Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- Canada Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
- Canada Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- Canada Antihypertensive Drugs Market, by Drug Class
-
Mexico
- Mexico Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- Mexico Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
- Mexico Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- Mexico Antihypertensive Drugs Market, by Drug Class
-
North America Antihypertensive Drugs Market, by Drug Class
- Europe
-
Europe Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
-
Europe Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
-
Europe Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- U. K.
- U.K. Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- U.K. Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
- U.K. Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- U.K. Antihypertensive Drugs Market, by Drug Class
- France
- France Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- France Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
- France Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- France Antihypertensive Drugs Market, by Drug Class
-
Germany
- Germany Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- Germany Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
- Germany Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- Germany Antihypertensive Drugs Market, by Drug Class
-
Italy
- Italy Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- Italy Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
- Italy Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- Italy Antihypertensive Drugs Market, by Drug Class
-
Spain
- Spain Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- Spain Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
- Spain Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- Spain Antihypertensive Drugs Market, by Drug Class
-
Rest of Europe
- Rest of Europe Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- Rest of Europe Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
- Rest of Europe Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- Rest of Europe Antihypertensive Drugs Market, by Drug Class
-
Europe Antihypertensive Drugs Market, by Drug Class
- Asia Pacific
-
Asia Pacific Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
-
Asia Pacific Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
-
Asia Pacific Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- China
- China Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- China Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
- China Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- China Antihypertensive Drugs Market, by Drug Class
- Japan
- Japan Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- Japan Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
- Japan Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- Japan Antihypertensive Drugs Market, by Drug Class
-
Germany
- Germany Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- Germany Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
- Germany Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- Germany Antihypertensive Drugs Market, by Drug Class
-
India
- India Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- India Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
- India Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- India Antihypertensive Drugs Market, by Drug Class
-
South Korea
- South Korea Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- South Korea Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
- South Korea Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- South Korea Antihypertensive Drugs Market, by Drug Class
-
South East Asia
- South East Asia Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- South East Asia Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
- South East Asia Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- South East Asia Antihypertensive Drugs Market, by Drug Class
-
Rest of Asia Pacific
- Rest of Asia Pacific Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- Rest of Asia Pacific Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
- Rest of Asia Pacific Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- Rest of Asia Pacific Antihypertensive Drugs Market, by Drug Class
-
Asia Pacific Antihypertensive Drugs Market, by Drug Class
- Latin America
-
Latin America Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
-
Latin America Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
-
Latin America Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- Brazil
- Brazil Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- Brazil Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
- Brazil Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- Brazil Antihypertensive Drugs Market, by Drug Class
- Argentina
- Argentina Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- Argentina Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
- Argentina Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- Argentina Antihypertensive Drugs Market, by Drug Class
-
Rest of Latin America
- Rest of Latin America Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- Rest of Latin America Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
- Rest of Latin America Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- Rest of Latin America Antihypertensive Drugs Market, by Drug Class
-
Latin America Antihypertensive Drugs Market, by Drug Class
- Middle East & Africa
-
Middle East & Africa Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
-
Middle East & Africa Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
-
Middle East & Africa Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- GCC Countries
- GCC Countries Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- GCC Countries Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
- GCC Countries Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- GCC Countries Antihypertensive Drugs Market, by Drug Class
- South Africa
- South Africa Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- South Africa Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
- South Africa Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- South Africa Antihypertensive Drugs Market, by Drug Class
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Antihypertensive Drugs Market, by Drug Class
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
- Rest of Middle East & Africa Antihypertensive Drugs Market, by Type
- Primary Hypertension
- Secondary Hypertension
- Rest of Middle East & Africa Antihypertensive Drugs Market, by End User
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- Rest of Middle East & Africa Antihypertensive Drugs Market, by Drug Class
-
Middle East & Africa Antihypertensive Drugs Market, by Drug Class
- North America
FAQ
Frequently Asked Question
What is the global demand for Antihypertensive Drugs in terms of revenue?
-
The global Antihypertensive Drugs valued at USD 25.5 Billion in 2023 and is expected to reach USD 33.86 Billion in 2032 growing at a CAGR of 3.2%.
Which are the prominent players in the market?
-
The prominent players in the market are Novartis AG., AstraZeneca plc, Lupin, Daiichi Sankyo Company, Limited, Johnson & Johnson, Pfizer Inc., Sun Pharmaceutical Industries Ltd., SANOFI, Boehringer Ingelheim International GmbH, Merck & Co. Inc.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 3.2% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Antihypertensive Drugs include
Which region accounted for the largest share in the market?
-
North America 4 was the leading regional segment of the Antihypertensive Drugs in 2023.